Fortress Biotech, Inc. (FBIO) stock
FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
$1.82+0.11 (+6.43%)
Close on Nov 17, 2026Market cap $66.94MP/E –Yield –
Fortress Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Fortress Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was $125.92M. For fiscal 2025 it was -$65.78M. The highest annual figure on record is -$2.35M in fiscal 2009.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$65.78M | – |
| FY2024 | Dec 31, 2024 | -$80.19M | – |
| FY2023 | Dec 31, 2023 | -$128.23M | – |
| FY2022 | Dec 31, 2022 | -$179.40M | – |
| FY2021 | Dec 31, 2021 | -$116.54M | – |
| FY2020 | Dec 31, 2020 | -$83.68M | – |
| FY2019 | Dec 31, 2019 | -$94.96M | – |
| FY2018 | Dec 31, 2018 | -$98.85M | – |
| FY2017 | Dec 31, 2017 | -$81.31M | – |
| FY2016 | Dec 31, 2016 | -$45.81M | – |
| FY2015 | Dec 31, 2015 | -$20.38M | – |
| FY2014 | Dec 31, 2014 | -$16.33M | – |
| FY2013 | Dec 31, 2013 | -$29.65M | – |
| FY2012 | Dec 31, 2012 | -$23.19M | – |
| FY2011 | Dec 31, 2011 | -$10.95M | – |
| FY2010 | Dec 31, 2010 | -$5.68M | – |
| FY2009 | Dec 31, 2009 | -$2.35M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$59.28M | – |
| Q1 FY2026 | Mar 31, 2026 | $203.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.54M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.11M | – |
| Q2 FY2025 | Jun 30, 2025 | -$27.56M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.56M | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.91M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$21.84M | – |
| Q1 FY2024 | Mar 31, 2024 | -$25.39M | – |
| Q4 FY2023 | Dec 31, 2023 | -$34.94M | – |
| Q3 FY2023 | Sep 30, 2023 | -$16.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$33.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$43.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$47.84M | – |
| Q3 FY2022 | Sep 30, 2022 | -$43.27M | – |
| Q2 FY2022 | Jun 30, 2022 | -$41.42M | – |
| Q1 FY2022 | Mar 31, 2022 | -$46.86M | – |
| Q4 FY2021 | Dec 31, 2021 | -$38.70M | – |
| Q3 FY2021 | Sep 30, 2021 | -$21.70M | – |
| Q2 FY2021 | Jun 30, 2021 | -$34.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$21.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$20.49M | – |
| Q3 FY2020 | Sep 30, 2020 | -$23.89M | – |
| Q2 FY2020 | Jun 30, 2020 | -$17.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$21.89M | – |
| Q4 FY2019 | Dec 31, 2019 | -$25.05M | – |
| Q3 FY2019 | Sep 30, 2019 | -$16.26M | – |
| Q2 FY2019 | Jun 30, 2019 | -$28.32M | – |
| Q1 FY2019 | Mar 31, 2019 | -$25.33M | – |
| Q4 FY2018 | Dec 31, 2018 | -$22.16M | – |
| Q3 FY2018 | Sep 30, 2018 | -$24.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$24.08M | – |
| Q1 FY2018 | Mar 31, 2018 | -$27.84M | – |
| Q4 FY2017 | Dec 31, 2017 | -$20.86M | – |
| Q3 FY2017 | Sep 30, 2017 | -$25.09M | – |
| Q2 FY2017 | Jun 30, 2017 | -$23.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$11.48M | – |
| Q4 FY2016 | Dec 31, 2016 | -$17.97M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.82M | – |
See a number that looks wrong?